The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

In the closing of the recent trading day, Boston Scientific (BSX) stood at $95.52, denoting a +1.48% change from the preceding trading day. Boston Scientific (NYSE:BSX) recently experienced a 4% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...